Elevance Health (NYSE:ELV) Stock: Insider Ratnakar Lavu Sells 1,300 Shares

Elevance Health, Inc. (NYSE:ELV) EVP Ratnakar Lavu sold 1,300 shares of the company’s stock in a transaction on Thursday, November 5th. The stock was sold at an average price of $440.00, for a total transaction of $572,000.00. Following the completion of the sale, the executive vice president owned 14,849 shares of the company’s stock, valued at $6,533,560. This represents a 8.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Elevance Health Trading Down 1.4%

Elevance Health stock opened at $426.17 on Friday. Elevance Health, Inc. has a one year low of $274.84 and a one year high of $450.69. The company’s fifty day moving average price is $412.92 and its two-hundred day moving average price is $373.58. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.47 and a quick ratio of 1.47. The company has a market capitalization of $92.08 billion, a price-to-earnings ratio of 18.17, a PEG ratio of 2.03 and a beta of 0.63.

Elevance Health (NYSE:ELV) last announced its quarterly earnings results on Wednesday, October 21st. The company reported $6.99 earnings per share for the quarter, topping analysts’ consensus estimates of $4.71 by $2.28. The company had revenue of $50.44 billion during the quarter, compared to analysts’ expectations of $49.28 billion. Elevance Health had a return on equity of 14.97% and a net margin of 2.55%. The business’s quarterly revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.03 earnings per share. On average, analysts forecast that Elevance Health, Inc. will post 29.15 earnings per share for the current fiscal year.

Elevance Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 18th. Investors of record on Friday, December 4th will be issued a $1.72 dividend. This represents a $6.88 annualized dividend and a yield of 1.6%. The ex-dividend date is Friday, December 4th. Elevance Health’s payout ratio is 29.34%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on ELV shares. Guggenheim increased their price target on Elevance Health from $460.00 to $485.00 and gave the company a “buy” rating in a report on Thursday, October 22nd. Wall Street Zen upgraded shares of Elevance Health from a “hold” rating to a “buy” rating in a research note on Saturday. UBS Group upped their price objective on shares of Elevance Health from $460.00 to $523.00 and gave the stock a “buy” rating in a report on Thursday, October 22nd. Weiss Ratings reiterated a “hold (c)” rating on shares of Elevance Health in a research note on Thursday, August 13th. Finally, Royal Bank Of Canada lifted their target price on shares of Elevance Health from $424.00 to $455.00 and gave the stock a “sector perform” rating in a report on Thursday, October 22nd. Fifteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $456.48.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. bought a new stake in Elevance Health in the 2nd quarter valued at $7,344,424,000. State Street Corp lifted its holdings in shares of Elevance Health by 1.3% during the 2nd quarter. State Street Corp now owns 10,426,610 shares of the company’s stock worth $4,032,283,000 after acquiring an additional 137,914 shares during the period. Wellington Management Group LLP lifted its holdings in shares of Elevance Health by 12.0% during the 2nd quarter. Wellington Management Group LLP now owns 9,213,513 shares of the company’s stock worth $3,563,142,000 after acquiring an additional 984,976 shares during the period. First Eagle Investment Management LLC boosted its position in shares of Elevance Health by 1.4% during the 2nd quarter. First Eagle Investment Management LLC now owns 4,188,196 shares of the company’s stock valued at $1,619,701,000 after acquiring an additional 55,905 shares in the last quarter. Finally, Bank of New York Mellon Corp acquired a new stake in shares of Elevance Health during the 2nd quarter valued at about $1,246,349,000. 89.24% of the stock is owned by institutional investors.

Key Elevance Health News

Here are the key news stories impacting Elevance Health this week:

• Positive Sentiment: Zacks Research raised its FY2026 EPS estimate to $29.02 from $27.06, and lifted forecasts for Q1 2027 and Q1 2028 to $11.73 and $12.61, respectively. An additional analyst also raised its Q2 EPS estimate, though the report did not provide the revised figure. Q2 EPS Estimate for Elevance Health Lifted by Analyst
• Neutral Sentiment: EVP Ratnakar Lavu sold 1,300 shares for $572,000, an 8.05% reduction in his holdings. He still directly owned 14,849 shares after the transaction, making the sale a limited insider-sentiment signal. SEC insider transaction filing
• Neutral Sentiment: A separate article considers what would need to be true for Elevance to be an attractive stock purchase, but the supplied article information does not state its conclusion. What Needs To Be True To Buy Elevance Health Stock?
• Negative Sentiment: Zacks Research lowered estimates for Q4 2026 EPS to $2.00 from $2.43, Q3 2027 to $6.01 from $6.70, and Q3 2028 to $7.09 from $7.75. These cuts temper the positive revisions and point to a less favorable outlook for some future quarters.

About Elevance Health

Elevance Health, Inc is a U.S. health benefits and services company. Formerly known as Anthem, Inc, it adopted the Elevance Health name in 2022 while retaining the Anthem brand for many of its health plans.

The company offers medical, pharmacy, dental, vision and behavioral health coverage, including plans for individuals and employers as well as programs serving Medicare and Medicaid members. Its services also include care management, pharmacy benefit services and other health-related capabilities through its Carelon business.

Elevance Health operates primarily in the United States, with health plans serving members across multiple states and access to broader provider networks through its Blue Cross Blue Shield affiliations.